AI Sight
PrivateLast Round
Seed
Sep 17, 2024
Total Funding Raised
$1.25M
Company Overview
AI Sight is a healthtech company that has developed a next-generation AI system for diabetic retinal screening.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Medical Devices, Computer Vision
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AI Sight Comparables
Compare AI Sight with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MONA Health | 91% | |
| OphtAI | 89% | |
| Eyenuk | 87% | |
AI Sight Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 17, 2024 | ||||
| Pre Seed | Feb 28, 2023 |
Key People
Founding team and executive leadership
AI Sight Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deepbridge Capital | Seed |
| Pitalia Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 17, 2024
$1.25M round from Deepbridge Capital and others.
AI Sight Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AI Sight's valuation, stock price, and market status.